ClinicalTrials.gov
public full text
Public Domain
The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients
The study was conducted to assess safety and immunogenicity of recombinant human erythropoietin (rhEPO) manufactured by Daewoong Pharmaceutical Co., Ltd was similar to biological products approved by the drug safety regulatory authority.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)#913264
- Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin#1101833
- Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation#1088138
- The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®#861426
- Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa#849813
Record · ID 831383
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive